<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" specific-use="sps-1.8" xml:lang="es" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">ode</journal-id>
			<journal-title-group>
				<journal-title>Odontoestomatología</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Odontoestomatología</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="epub">1688-9339</issn>
			<issn pub-type="ppub">0797-0374</issn>
			<publisher>
				<publisher-name>Facultad de Odontología - Universidad de la República</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.22592/ode2020n36a5</article-id>
			<article-id pub-id-type="publisher-id">00006</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Investigación</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Perfil del Carcinoma Oral de Células Escamosas en el Laboratorio de Anatomía Patológica de la Facultad de Odontología de la Universidad de la República, período 1982-2015</article-title>
				<trans-title-group xml:lang="en">
					<trans-title>Profile of oral squamous cell carcinoma at the Anatomic Pathology Laboratory of the School of Dentistry of Universidad de la República, 1982-2015 period</trans-title>
				</trans-title-group>
				<trans-title-group xml:lang="pt">
					<trans-title>Perfil do carcinoma epidermoide oral no Laboratório de Anatomia Patológica da Faculdade de Odontologia da Universidade da República, período 1982-2015</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-9006-1680</contrib-id>
					<name>
						<surname>González Umpiérrez</surname>
						<given-names>Natalia</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-0888-507X</contrib-id>
					<name>
						<surname>Beovide Cortegoso</surname>
						<given-names>Verónica</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="original">Cátedra de Anatomía Patológica. Facultad de Odontología, Universidad de la República, Montevideo, Uruguay</institution>
				<institution content-type="normalized">Universidad de la República</institution>
				<institution content-type="orgdiv2">Cátedra de Anatomía Patológica</institution>
				<institution content-type="orgdiv1">Facultad de Odontología</institution>
				<institution content-type="orgname">Universidad de la República</institution>
				<country country="UY">Uruguay</country>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="original">Cátedra de Anatomía Patológica. Facultad de Odontología , Universidad de la República, Montevideo, Uruguay</institution>
				<institution content-type="normalized">Universidad de la República</institution>
				<institution content-type="orgdiv2">Cátedra de Anatomía Patológica</institution>
				<institution content-type="orgdiv1">Facultad de Odontología</institution>
				<institution content-type="orgname">Universidad de la República</institution>
				<country country="UY">Uruguay</country>
			</aff>
			<!--<pub-date date-type="pub" publication-format="electronic">
				<day>01</day>
				<month>12</month>
				<year>2020</year>
			</pub-date>
			<pub-date date-type="collection" publication-format="electronic">-->
				<pub-date pub-type="epub-ppub">
			<season>Jul-Dec</season>
				<year>2020</year>
			</pub-date>
			<volume>XXII</volume>
			<issue>36</issue>
			<fpage>34</fpage>
			<lpage>43</lpage>
			<history>
				<date date-type="received">
					<day>29</day>
					<month>10</month>
					<year>2019</year>
				</date>
				<date date-type="accepted">
					<day>08</day>
					<month>09</month>
					<year>2020</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/" xml:lang="es">
					<license-p>Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons</license-p>
				</license>
			</permissions>
			<abstract>
				<title>Resumen:</title>
				<p>El Carcinoma oral de células escamosas es la patología oral maligna más frecuente, asociada principalmente al tabaco, alcohol y virus del papiloma humano. </p>
				<p>El objetivo del estudio fue determinar el perfil de dicha patología, en el Laboratorio de Anatomía Patológica de la Facultad de Odontología de la Universidad de la República entre 1982-2015. Se realizó un estudio retrospectivo, transversal, analítico. Análisis estadístico usando el modelo de Cox, el test exacto de Fisher y el método de Kaplan Meier. Con 207 casos el 59,9% fueron hombres y el 98.5% mayores de 40 años. Localizándose preferentemente en la lengua, con predominio de los carcinomas histopatologicamente bien y moderadamente diferenciados. Se encontró asociación entre el grado histopatológico, género y edad; con un tiempo medio de sobrevida de 2.36 años y una tasa de sobrevida del 43% a los 5 años. El estudio permitió conocer dicha patología en un servicio de referencia y generar una base de datos para posteriores estudios.</p>
			</abstract>
			<trans-abstract xml:lang="en">
				<title>Abstract</title>
				<p>Oral squamous cell carcinoma is the most frequent malignant oral pathology, mainly associated with tobacco, alcohol, and human papillomavirus.</p>
				<p>This study aimed to determine the profile of this pathology at the Laboratory of Anatomic Pathology of the School of Dentistry of Universidad de la República between 1982 and 2015. A retrospective, cross-sectional, analytical study was conducted. Statistical analysis performed using the Cox model, Fisher’s exact test, and the Kaplan-Meier method. Of 207 cases, 59.9% were men and 98.5% older than 40. It is usually located on the tongue, with a predominance of histopathologically well and moderately differentiated carcinomas. There was an association between histopathological grade, gender, and age, with an average survival time of 2.36 years and a 43% five-year survival rate. The study allowed us to determine the situation of this pathology in a reference health service and create a database for subsequent studies. </p>
			</trans-abstract>
							<trans-abstract xml:lang="pt">
				<title>Sumário:</title>
				<p>O carcinoma epidermóide de boca é a patologia maligna mais frequente, principalmente associada ao tabaco, álcool e papiloma vírus humano.</p>
				<p>O objetivo do estudo foi determinar o perfil dessa patologia, no Laboratório de Anatomia Patológica da Faculdade de Odontologia da Universidade da República entre 1982-2015. Foi realizado um estudo analítico retrospectivo, transversal. Análise estatística pelo modelo de Cox, teste exato de Fisher e método de Kaplan Meier. Em 207 casos, 59,9% eram homens e 98,5% tinham mais de 40 anos. De preferência localizado na língua, com predominância de carcinomas histopatologicamente bem e moderadamente diferenciados. Foi encontrada associação entre grau histopatológico, sexo e idade; com tempo médio de sobrevivência de 2,36 anos e taxa de sobrevivência de 43% aos 5 anos. O estudo permitiu conhecer essa patologia em um serviço de referência e gerar um banco de dados para estudos subsequentes.</p>
			</trans-abstract>
			<kwd-group xml:lang="es">
				<title>Palabras claves:</title>
				<kwd>Carcinoma de células escamosas de cabeza y cuello</kwd>
				<kwd>Epidemiología y Sobrevida</kwd>
			</kwd-group>
			<kwd-group xml:lang="en">
				<title>Keywords:</title>
				<kwd>head and neck squamous cell carcinoma</kwd>
				<kwd>epidemiology</kwd>
				<kwd>survival</kwd>
			</kwd-group>
			<kwd-group xml:lang="pt">
				<title>Palavras-chave:</title>
				<kwd>Carcinoma espinocelular de cabeça e pescoço</kwd>
				<kwd>Epidemiologia e Sobrevivência</kwd>
			</kwd-group>
			<counts>
				<fig-count count="2"/>
				<table-count count="4"/>
				<equation-count count="0"/>
				<ref-count count="45"/>
				<page-count count="10"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>Introducción y Antecedentes</title>
			<p>El Carcinoma oral de células escamosas (COCE) es la patología oral maligna de mayor frecuencia, representa del 2 al 3% de todas las neoplasias malignas y hasta el 80-90% de las que asientan en la cavidad bucal <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref>.</p>
			<p>El COCE es un tumor sólido maligno, que se origina en el epitelio escamoso estratificado de la mucosa del tracto aerodigestivo superior, se caracteriza por presentar diferentes grados de diferenciación histológica y un elevado potencial invasivo y metastásico <xref ref-type="bibr" rid="B9"><sup>9</sup></xref>; su etiología se asocia principalmente a factores de riesgo como el tabaco, alcohol y virus de papiloma humano 16 y 18 (VPH) (10-13).</p>
			<p>En 2018 el Global Cancer Observatory (GLOBOCAN) reporta los siguientes datos para Uruguay: en una población de 3.469.551 se registraron 15.101 nuevos casos de cáncer, con una mortalidad de 8.589 y una prevalencia en 5 años de 35.478; según fuentes del Registro Nacional de Cáncer (RNC) y la Organización Mundial de la Salud (OMS) <xref ref-type="bibr" rid="B14"><sup>14</sup></xref>.</p>
			<p>La situación epidemiológica del Uruguay en relación al cáncer, publicada recientemente por el RNC reporta los siguientes datos a nivel buco-faríngeo para el período 2011-2015 (expresado en tasas ajustadas cada 100.000 habitantes): un total de 1.529 nuevos casos (1.107 hombres y 422 mujeres), localizado con mayor frecuencia en la lengua (378 casos) sin distinción de sitio anatómico lingual, una incidencia de 10.17 y 2.81 para hombres y mujeres respectivamente y mortalidad 6.67 en hombres y 1.21 en mujeres <xref ref-type="bibr" rid="B15"><sup>15</sup></xref>.</p>
			<p>Morfológicamente el COCE se presenta como una proliferación neoplásica epitelial maligna, conformada por nidos, cordones e islotes que recuerdan en mayor o menor grado al epitelio escamoso de la mucosa de revestimiento de la cual derivan. Actualmente la tipificación histológica del COCE se realiza en base a la clasificación histológica de la OMS y al frente de invasión tumoral; en COCE bien diferenciados, moderadamente diferenciados e indiferenciado <xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref>. </p>
			<p>El COCE es una neoplasia agresiva con un comportamiento biológico impredecible y un pronóstico desfavorable <xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. La agresividad de esta neoplasia maligna se evidencia en que a pesar de las estrategias terapéuticas disponibles en la actualidad, que incluyen su extirpación quirúrgica ya sea en forma exclusiva o en combinación con radioterapia y/o quimioterapia, la tasa de sobrevida y la tasa de recurrencia a los 5 años es deficiente, sobreviviendo solo el 50% de los pacientes diagnosticados y tratados <xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref>, situación que se ha mantenido inmodificable en las últimas cinco décadas <xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. El pronóstico se relaciona a factores como el tamaño tumoral, la presencia de ganglios linfáticos metastásicos, el grado de diferenciación tumoral, la invasión de estructuras adyacentes, la localización y el tratamiento realizado <xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref>. El sistema de estadificación TNM del inglés TNM Staging System, donde T significa tumor primario, N ganglios linfáticos regionales y M presencia de metástasis a distancia, es un método universal de estadificación de la enfermedad en el paciente con cáncer, el cual permite la toma de decisiones terapéuticas. Fue actualizado en 2017 para cada topografía, además de identificarse los COCE VPH+ y VPH <xref ref-type="bibr" rid="B25"><sup>25</sup></xref>.</p>
			<p>El objetivo de este estudio fue determinar el perfil del COCE en el Laboratorio de Anatomía Patológica de la Facultad de Odontología (LAPFO) de la Universidad de la República (UdelaR), en el periodo 1982-2015. Describiendo la distribución de acuerdo a los parámetros clínico-morfológicos (edad, género, localización y grado histopatológico) y determinar la tasa de sobrevida.</p>
		</sec>
		<sec sec-type="methods">
			<title>Metodología</title>
			<sec>
				<title>1- Consideraciones éticas:</title>
				<p>El proyecto cuenta con la aprobación del comité de ética de la Facultad de Odontología - UdelaR Montevideo -Uruguay. (Expediente 163/16).</p>
			</sec>
			<sec>
				<title>2- Diseño del estudio:</title>
				<p>Estudio retrospectivo, transversal y analítico, tipo de muestreo no probabilístico por conveniencia de acuerdo a los criterios de inclusión y exclusión propuestos para el trabajo. La población comprendió todos los registros biópsicos del LAPFO (11.321) durante el periodo 1982-2015 y la muestra se constituyó por todos los casos con diagnóstico histopatológico de COCE de la mucosa bucal. Del total de registros biópsicos en dicho período (11.321) se obtuvo una muestra de 207 casos de COCE (1,8%) que cumplieron con los criterios de inclusión y exclusión planteados a continuación.</p>
			</sec>
			<sec>
				<title>3- Criterios de inclusión y exclusión:</title>
				<p><italic>Criterios de inclusión:</italic> COCE con datos clínico morfológicos completos, donde se registren las variables: edad, género, localización y grado histopatológico de la lesión. Se aceptó como diagnóstico histopatológico de COCE el registrado en el informe biópsico que cumplieran con los criterios histológicos de malignidad planteados por la OMS (bien diferenciados, moderadamente diferenciados e indiferenciados), se consideró la posibilidad de una reevaluación del diagnóstico histopatológico en aquellos casos que el grado histopatológico no estuviera detallado según los criterios establecidos (no fue necesaria la reevaluación en ningún caso); en los casos que para un paciente existieran dos registros (biopsia incisional y excisional), fue contabilizado como un solo caso (para evitar la duplicación de casos) y la graduación histológica registrada del COCE fue la detallada en la biopsia excisional, mientras que para la fecha de inicio de la enfermedad se consideró la registrada en la primer biopsia con diagnóstico de COCE.</p>
				<p>Para determinar la tasa de sobrevida de los pacientes con COCE se constituyó una muestra, donde el criterio de inclusión fue que el registro contara con la cédula de identidad del paciente, dato necesario para ser localizados en la base de datos del RNC, (n=99).</p>
				<p><italic>Criterios de exclusión:</italic> Se excluyeron los casos con datos incompletos, la ausencia de alguna de las variables (edad, género, localización y graduación histológica).</p>
			</sec>
			<sec>
				<title>4- Análisis estadístico:</title>
				<p>Se realizó estadística descriptiva, se buscó establecer relaciones significativas entre los diferentes parámetros clínico-morfológicos mediante el test exacto de Fisher. Se construyeron curvas de sobrevida mediante la metodología de Kaplan Meier. Las pruebas de hipótesis fueron realizadas a un nivel de 5% y los cálculos en el software de uso libre R utilizando la librería survival. Atendiendo al posible efecto del género, edad, grado histopatológico y localización agrupada de los tumores se realizó el análisis mediante el modelo de riesgos proporcionales de Cox. La selección de las variables fue llevada a cabo mediante un procedimiento back Ward, luego de ajustados los modelos se verificó la validez del supuesto de proporcionalidad.</p>
			</sec>
		</sec>
		<sec sec-type="results">
			<title>Resultados</title>
			<p>Los resultados se muestran en el <xref ref-type="table" rid="t1">Cuadro 1</xref><bold>,</bold> se registró un rango etario entre 16 y 99 años, con una media de 63 años ± 12.57, 41.5% (86) entre los 41-60 años y 47.8% (99) entre los 61-80 años. El 59.9% (124) fueron masculinos, con una relación m: f de 1.5:1. En relación al grado histopatológico, 44.4% (92) fueron carcinomas bien diferenciados, 44.9% (93) moderadamente diferenciados y 10.6% (22) indiferenciados. La localización más frecuente fue la lengua con 26.6% (55) y el reborde alveolar con un 23.7% (49). </p>
			<p>
				<table-wrap id="t1">
					<label>Cuadro 1:</label>
					<caption>
						<title>Frecuencias univariadas del COCE (n=207)</title>
					</caption>
					<graphic xlink:href="1688-9339-ode-22-36-34-gt1.png"/>
				</table-wrap>
			</p>
			<p>Al realizar la asociación entre variables se observó que el grado histopatológico en relación al género y la edad fueron significativos, mostrando que los hombres tienen mayor proporción de COCE moderadamente diferenciado y las mujeres mayor proporción de COCE bien diferenciado (p-valor de 0.031) <xref ref-type="table" rid="t2">Tabla 1</xref>; en cuanto a la edad, los mayores de 81 años tienen mayor proporción de COCE indiferenciado (p-valor 0.027) <xref ref-type="table" rid="t3">Tabla 2</xref>. </p>
			<p>
				<table-wrap id="t2">
					<label>Tabla 1:</label>
					<caption>
						<title>Asociación entre grado histopatológico y género</title>
					</caption>
					<graphic xlink:href="1688-9339-ode-22-36-34-gt2.png"/>
					<table-wrap-foot>
						<fn id="TFN1">
							<p>Test exacto de Fisher, p-valor: 0,031</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</p>
			<p>
				<table-wrap id="t3">
					<label>Tabla 2:</label>
					<caption>
						<title>Asociación entre grado histopatológico y edad</title>
					</caption>
					<graphic xlink:href="1688-9339-ode-22-36-34-gt3.png"/>
				</table-wrap>
			</p>
			<p>El análisis multivariado en relación a la localización no mostró asociación significativa, posiblemente debido a las múltiples localizaciones del COCE en la mucosa bucal, en este estudio se agruparon en 8 categorías. En las mujeres las localizaciones de mayor frecuencia fueron el reborde alveolar 28.9% (24) y la lengua 26.5% (22), mientras que en los hombres la lengua fue 26.6% (33) y 20.2% (25) el reborde alveolar.</p>
			<p>Para el análisis de sobrevida se trabajó con la muestra de 99 pacientes, entre los cuales se observó el evento de fallecimiento en 57 casos, el resto correspondieron a censuras. Se construyó la curva de sobrevida <xref ref-type="fig" rid="f1">Figura 1</xref>, a partir de la cual se estimó que el tiempo medio de sobrevida fue de 2.36 años con un intervalo de confianza (1.60 - 8.24) y la tasa de sobrevida a los 5 años fue del 43%, sin considerar los estadios del sistema TNM debido al no registro de los mismos en los archivos.</p>
			<p>
				<fig id="f1">
					<label>Fig.1: </label>
					<caption>
						<title>Curva de sobrevida, Kaplan-Meier</title>
					</caption>
					<graphic xlink:href="1688-9339-ode-22-36-34-gf1.jpg"/>
				</fig>
			</p>
			<p>Al asociar el riesgo de fallecimiento en función del género, edad, grado histopatológico y localización, se encontró asociación estadísticamente significativa con el grado histológico. El modelo final se presenta en el <xref ref-type="table" rid="t4">Cuadro 2</xref>, donde se observa que los pacientes con diagnóstico de COCE moderadamente diferenciados presentan casi el doble de riesgo de fallecer que los pacientes con COCE bien diferenciado (p-valor 0,031). Al analizar los COCE indiferenciados se observó el evento de fallecimiento en el total de los casos, a los 7 años aproximadamente del seguimiento, a diferencia de los COCE bien diferenciados que al final del estudio contaban aún con pacientes vivos <xref ref-type="fig" rid="f2">Fig. 2</xref>.</p>
			<p>
				<table-wrap id="t4">
					<label>Cuadro 2:</label>
					<caption>
						<title>Modelo final de riesgo proporcional de COX</title>
					</caption>
					<graphic xlink:href="1688-9339-ode-22-36-34-gt4.png"/>
				</table-wrap>
			</p>
			<p>
				<fig id="f2">
					<label>Fig. 2:</label>
					<caption>
						<title>Curvas de sobrevida según grado histopatológico</title>
					</caption>
					<graphic xlink:href="1688-9339-ode-22-36-34-gf2.png"/>
				</fig>
			</p>
		</sec>
		<sec sec-type="discussion">
			<title>Discusión</title>
			<p>El estudio del COCE es de gran importancia debido a su alta morbilidad y mortalidad, siendo de gran utilidad obtener información relevante que permita comparar resultados con otros centros especializados en patología bucal, aportando conocimiento sobre la sobrevida y las características clínico-patológicas.</p>
			<p>El presente estudio permitió obtener información institucional para la FO de la UdelaR, estableciendo el perfil del COCE en el LAPFO, obteniendo una base de datos importante para posteriores estudios. </p>
			<p>En nuestro trabajo tuvimos algunas limitantes debido a la falta de registro adecuado en las fichas anátomo-patológicas, lo que dificulta la estadificación TNM y la evaluación de factores de riesgo. Aun así destacamos la importancia de contar con una cohorte de 99 pacientes para el análisis de sobrevida. </p>
			<p>En este estudio, el 59.9% de los COCE afectó a los hombres, dato que coincide con la literatura<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref> ; sin embargo se encontró diferencias en cuanto a la relación m:f 1.5:1 de nuestro estudio con los mostrados por el Instituto Nacional de Cáncer (INCA) en Brasil que reporto una proporción mayor de 3.7:1 <xref ref-type="bibr" rid="B28"><sup>28</sup></xref> y los recientemente aportados por el RNC en Uruguay que publicó una proporción 3.6:1 para hombres y mujeres respectivamente <xref ref-type="bibr" rid="B15"><sup>15</sup></xref>. La mayor frecuencia en hombres coincide con lo reportado en GLOBOCAN 2018 <xref ref-type="bibr" rid="B14"><sup>14</sup></xref> y otros autores, donde se evidencia que el COCE es dos o tres veces más frecuente en hombres en la mayoría de los grupos étnicos, con cierta tendencia en los últimos años al aumento del COCE en las mujeres debido al mayor consumo de tabaco, dicho dato podría explicar la relación 1,5:1 obtenida en nuestro estudio<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref>.</p>
			<p>Un trabajo retrospectivo publicado en 2014 por Momares y col. con 217 pacientes diagnosticados con COCE entre 1989 y 2010, del departamento de Patología Oral de la Escuela de Odontología Universidad Mayor de Chile, mostró resultados similares a los obtenidos en nuestro estudio, al compararlos se encontró que la distribución por género, la proporción entre ambos, el rango etario y el promedio de edad fueron casi idénticos. La lengua y el reborde alveolar fueron las localizaciones más frecuentes para ambos, con algunas diferencias en el resto de las localizaciones. Respecto al grado de diferenciación histológico ambos estudios encontraron que los COCE bien diferenciados y moderadamente diferenciados fueron más prevalentes que los COCE indiferenciados<xref ref-type="bibr" rid="B30"><sup>30</sup></xref>. </p>
			<p>Al analizar la edad de presentación del COCE, en nuestro trabajo la media fue de 63 ± 12,57 años con un rango etario de 16 a 99 años, una frecuencia de 41,5 % de los COCE entre los 41 y 60 años, aumentando a 47,8 % en el grupo de 61-80 años. Oliveira y col. en 2015 reportan en un Hospital Público de Uruguay un promedio de 60,75 ± 11,26 años, similar al observado (19). La literatura reporta que más del 90% se diagnostican en mayores de 40 años, y más del 50% en individuos con más de 65 años, en nuestro estudio el 98.5% se presentó en individuos mayores de 40 años y el 57% en mayores de 60 años <xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B33"><sup>33</sup></xref>.</p>
			<p>Si analizamos la edad de presentación del COCE según el género en nuestro estudio, podemos destacar que el 80% de las mujeres y el 96 % de los hombres tienen entre 41 y 80 años, de esos grupos más del 50% se encuentran en el rango de mayor edad (61 a 80 años). En el análisis de los rangos etarios observamos que en el grupo de menores de 40 años no existían registros de COCE en hombres, mientras que en el grupo de mayores de 81 años, las mujeres registran un número casi tres veces mayor a los hombres.</p>
			<p>La localización de preferencia fue la lengua con un 26.6%, en concordancia con un trabajo realizado en el Laboratorio de Anatomía Patológica del INCA del Uruguay en 2017, como lo reportado en la literatura en la mayoría de los trabajos sobre COCE <xref ref-type="bibr" rid="B34"><sup>34</sup></xref>. A diferencia con lo visto en la segunda localización más frecuente (reborde alveolar con 23,7%), donde la mayoría de los estudios reporta como segunda localización al piso de boca y/o paladar, esta diferencia puede estar vinculada a la forma de agrupar las localizaciones del COCE <xref ref-type="bibr" rid="B35"><sup>35</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B37"><sup>37</sup></xref> .</p>
			<p>Al analizar el grado de diferenciación histopatológico encontramos resultados similares a los obtenidos en nuestro estudio, Wei-ping Jie y col. reportan el 90,8% de los casos fueron los COCE bien diferenciados y moderadamente diferenciados <xref ref-type="bibr" rid="B38"><sup>38</sup></xref>. Otros estudios mostraron datos similares, Sairay col. en Pakistán para el período 2015-2016 mostró que el 52% de los COCE fueron moderadamente diferenciados y el 42% bien diferenciados <xref ref-type="bibr" rid="B39"><sup>39</sup></xref>, mientras Gul y col. obtuvieron en un Hospital terciario del sur de Punjab India, un 43% de pacientes con COCE bien diferenciado, 38% moderadamente diferenciado y 20% con COCE indiferenciado <xref ref-type="bibr" rid="B40"><sup>40</sup></xref>. Leite y col. en 2018 en un estudio de Brasil de COCE en una población de bajo desarrollo económico, n=194 casos, el 54,6% fueron bien diferenciados, 37,1% moderadamente diferenciados y 5,2% carcinomas indiferenciados, este estudio reporta un perfil similar a nuestro estudio <xref ref-type="bibr" rid="B41"><sup>41</sup></xref>. </p>
			<p>Al realizar la asociación entre las variables, se observa significancia estadística del grado histopatológico del COCE en relación al género y edad. Los hombres presentaron mayor proporción de carcinomas moderadamente diferenciados y las mujeres mayor proporción de COCE bien diferenciados; indicando que a mayor edad, mayor proporción de carcinomas indiferenciados, similar a lo encontrado en un estudio publicado en 2010 sobre las Características clínico-histopatológicas del COCE en el Hospital Universitario San Vicente de Paúl, Colombia <xref ref-type="bibr" rid="B42"><sup>42</sup></xref>.</p>
			<p>La sobrevida de los pacientes con COCE a los 5 años fue de 43%, similar a lo reportado por Momares y col. en Chile que fue del 46%, mientras que el tiempo medio de sobrevida para ellos fue de 6,9 años, superior al encontrado en nuestro estudio que fue de 2.36 años <xref ref-type="bibr" rid="B30"><sup>30</sup></xref>. Otros autores reportan para el COCE una sobrevida que va del 30% a 50% <xref ref-type="bibr" rid="B33"><sup>33</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref>. </p>
			<p>Oliveira y col. muestran una tasa de sobrevida global aún menor, con una supervivencia a los 5 años del 24% <xref ref-type="bibr" rid="B19"><sup>19</sup></xref>. Bonfante y col. en 2014 en un estudio nacional del Sistema Único de Salud de Brasil en el período 2000-2006, reportan datos de sobrevida específica a los 5 años para el cáncer de boca de 4,6 años y una sobrevida global a los 5 años de 2,6 años similar a nuestro estudio (2,36 años) <xref ref-type="bibr" rid="B44"><sup>44</sup></xref>. Otra investigación con 274 casos de la Universidad de Buenos Aires (Argentina) que evaluó la sobrevida global para el cáncer de boca, reportó una tasa del 39% a los 5 años <xref ref-type="bibr" rid="B45"><sup>45</sup></xref>. </p>
		</sec>
		<sec sec-type="conclusions">
			<title>Conclusiones</title>
			<p>En general el estudio del COCE en Uruguay es escaso, principalmente en lo referido al pronóstico y sobrevida de los pacientes, estudios retrospectivos como el realizado cuentan con limitaciones importantes debido a la falta de registros completos, ausencia en la mayoría de los casos de datos clínicos relevantes para establecer un sistema de estatificación TNM y fundamentalmente a la falta de seguimiento de los pacientes. De todas maneras estos estudios descriptivos sirven como fuente de hipótesis para posteriores estudios analíticos.</p>
			<p>Considerando la alta mortalidad y morbilidad del COCE, los profesionales de la salud deberíamos considerar la importancia de la detección temprana de estas lesiones y la educación sobre los factores de riesgo ya conocidos, como el tabaco, alcohol e infección con el VPH, teniendo en cuenta que uno de los factores más importantes en relación al mal pronóstico del COCE es el diagnóstico tardío.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>Referencias </title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>Maraboli-Contreras S, Adorno-Farias D, Maturana-Ramirez A, Rojas-Alcayaga G, Fuentes-Alburquenque M, Espinoza-SantanderI. Sobrevida de carcinoma oral de células escamosas: reporte de la Universidad de Chile.Rev. Clin. Periodoncia Implantol. Rehabil. Oral. 2018; 11 (3): 147-151.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Maraboli-Contreras</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Adorno-Farias</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Maturana-Ramirez</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Rojas-Alcayaga</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Fuentes-Alburquenque</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Espinoza-Santander</surname>
							<given-names>I</given-names>
						</name>
					</person-group>
					<article-title>Sobrevida de carcinoma oral de células escamosas reporte de la Universidad de Chile</article-title>
					<source>Rev. Clin. Periodoncia Implantol. Rehabil Oral</source>
					<year>2018</year>
					<volume>11</volume>
					<issue>3</issue>
					<fpage>147</fpage>
					<lpage>151</lpage>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65 (2): 87-108.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Torre</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Bray</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Siegel</surname>
							<given-names>RL</given-names>
						</name>
						<name>
							<surname>Ferlay</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Lortet-Tieulent</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Jemal</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Global cancer statistics, 2012</article-title>
					<source>CA Cancer J Clin</source>
					<year>2015</year>
					<volume>65</volume>
					<issue>2</issue>
					<fpage>87</fpage>
					<lpage>108</lpage>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncology. 2009; 45: 309-316.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Warnakulasuriya</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Global epidemiology of oral and oropharyngeal cancer</article-title>
					<source>Oral Oncology</source>
					<year>2009</year>
					<volume>45</volume>
					<fpage>309</fpage>
					<lpage>316</lpage>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>Neville BW. Patologia oral e maxilofacial. 4. ed. Rio de Janeiro: Elsevier, 2016. 912 p.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Neville</surname>
							<given-names>BW</given-names>
						</name>
					</person-group>
					<source>Patologia oral e maxilofacial</source>
					<edition>4. ed</edition>
					<publisher-loc>Rio de Janeiro</publisher-loc>
					<publisher-name>Elsevier</publisher-name>
					<year>2016</year>
					<fpage>912 p</fpage>
					<lpage>912 p</lpage>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>Licitra L, Locati LD, Bossi P, Cantù G. Head and neck tumors other than squamous cell carcinoma. Curr Opin Oncol. 2004; 16 (3): 236-41.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Licitra</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Locati</surname>
							<given-names>LD</given-names>
						</name>
						<name>
							<surname>Bossi</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Cantù</surname>
							<given-names>G</given-names>
						</name>
					</person-group>
					<article-title>Head and neck tumors other than squamous cell carcinoma</article-title>
					<source>Curr Opin Oncol</source>
					<year>2004</year>
					<volume>16</volume>
					<issue>3</issue>
					<fpage>236</fpage>
					<lpage>241</lpage>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>Johnson NW, Jayasekara P, Amarasinghe AAHK. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and etiology. Periodontol 2000. 2011 ; 57 (1): 19-37.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Johnson</surname>
							<given-names>NW</given-names>
						</name>
						<name>
							<surname>Jayasekara</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Amarasinghe</surname>
							<given-names>AAHK</given-names>
						</name>
					</person-group>
					<article-title>Squamous cell carcinoma and precursor lesions of the oral cavity epidemiology and etiology</article-title>
					<source>Periodontol 2000</source>
					<year>2011</year>
					<volume>57</volume>
					<issue>1</issue>
					<fpage>19</fpage>
					<lpage>37</lpage>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumours: Pathology and genetics Head and Neck tumours. International Agency for Research on Cancer, Lyon, France 2005; 168-175</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Barnes</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Eveson</surname>
							<given-names>JW</given-names>
						</name>
						<name>
							<surname>Reichart</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Sidransky</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<source>World Health Organization classification of tumours: Pathology and genetics Head and Neck tumours</source>
					<publisher-name>International Agency for Research on Cancer</publisher-name>
					<publisher-loc>Lyon, France</publisher-loc>
					<year>2005</year>
					<fpage>168</fpage>
					<lpage>175</lpage>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ. WHO classification of head and neck tumours. International Agency for Research on Cancer. 4th ed. 2017.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>El-Naggar</surname>
							<given-names>AK</given-names>
						</name>
						<name>
							<surname>Chan</surname>
							<given-names>JKC</given-names>
						</name>
						<name>
							<surname>Rubin Grandis</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Takata</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Slootweg</surname>
							<given-names>PJ</given-names>
						</name>
					</person-group>
					<source>WHO classification of head and neck tumours</source>
					<publisher-name>International Agency for Research on Cancer</publisher-name>
					<edition>4th ed</edition>
					<year>2017</year>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>Kang H, Kiess A, Chung C. Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol. 2015; 12: 11-26.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kang</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Kiess</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Chung</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Emerging biomarkers in head and neck cancer in the era of genomics</article-title>
					<source>Nat Rev Clin Oncol</source>
					<year>2015</year>
					<volume>12</volume>
					<fpage>11</fpage>
					<lpage>26</lpage>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>Miguel Cruz PA, Niño Peña A, Batista Marrero K, Miguel-Soca PE. Factores de riesgo de cáncer bucal. Rev Cubana Estomatol. 2016; 53 (3): 128-45.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Miguel Cruz</surname>
							<given-names>PA</given-names>
						</name>
						<name>
							<surname>Niño Peña</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Batista Marrero</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Miguel-Soca</surname>
							<given-names>PE</given-names>
						</name>
					</person-group>
					<article-title>Factores de riesgo de cáncer bucal</article-title>
					<source>Rev Cubana Estomatol</source>
					<year>2016</year>
					<volume>53</volume>
					<issue>3</issue>
					<fpage>128</fpage>
					<lpage>145</lpage>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>Jiang X, Wu J, Jiexue Wang RH. Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways. Tob Induc Dis. 2019; 17.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jiang</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Wu</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Jiexue Wang</surname>
							<given-names>RH</given-names>
						</name>
					</person-group>
					<article-title>Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways</article-title>
					<source>Tob Induc Dis</source>
					<year>2019</year>
					<fpage>17</fpage>
					<lpage>17</lpage>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>Auluck A, Hislop G, Bajdik C, Poh C, Zhang L RM. Trends in oro- pharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer. 2010; 116: 2635-2644.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Auluck</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Hislop</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Bajdik</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Poh</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Zhang L</surname>
							<given-names>RM</given-names>
						</name>
					</person-group>
					<article-title>Trends in oro- pharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population the British Columbia experience</article-title>
					<source>Cancer</source>
					<year>2010</year>
					<volume>116</volume>
					<fpage>2635</fpage>
					<lpage>2644</lpage>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncology. 2015; 51.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Young</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Xiao</surname>
							<given-names>CC</given-names>
						</name>
						<name>
							<surname>Murphy</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Moore</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Fakhry</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Day</surname>
							<given-names>TA</given-names>
						</name>
					</person-group>
					<article-title>Increase in head and neck cancer in younger patients due to human papillomavirus (HPV)</article-title>
					<source>Oral Oncology</source>
					<year>2015</year>
					<volume>51</volume>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.31937">https://doi.org/10.1002/ijc.31937</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ferlay</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Colombet</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Soerjomataram</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Mathers</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Parkin</surname>
							<given-names>DM</given-names>
						</name>
						<name>
							<surname>Piñeros</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Znaor</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Bray</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods</article-title>
					<source>Int J Cancer</source>
					<year>2018</year>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.31937">https://doi.org/10.1002/ijc.31937</ext-link>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>Comisión Honoraria de Lucha Contra el Cáncer. Situacion Epidemiologica del Uruguay en relacion al Cancer. Regist Nac del Cáncer, Com Honor Lucha Contra el Cáncer. 2019;1-61.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<collab>Com Honor Lucha Contra el Cáncer</collab>
					</person-group>
					<source>Situacion Epidemiologica del Uruguay en relacion al Cancer</source>
					<year>2014</year>
					<publisher-loc>Registro Nacional de Cáncer</publisher-loc>
					<publisher-name>Comisión Honoraria de lucha contra el Cáncer</publisher-name>
					<year>2019</year>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>Lopes KM,Souza JA, Lacerda de Souza L, Akiko ML, Guimarão DM, Pontes HA . La proteína Ki-67 predice la supervivencia en las células de carcinoma escamoso oral: un estudio inmunohistoquímico. Braz. res oral. 2017; 31: e66.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lopes</surname>
							<given-names>KM</given-names>
						</name>
						<name>
							<surname>Souza</surname>
							<given-names>JA</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>Lacerda de Souza L.Akiko ML.Guimarão DM.Pontes HA</collab>
					</person-group>
					<article-title>La proteína Ki-67 predice la supervivencia en las células de carcinoma escamoso oral un estudio inmunohistoquímico</article-title>
					<source>Braz. res oral</source>
					<year>2017</year>
					<volume>31</volume>
					<elocation-id>e66</elocation-id>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>Majumdar B, Shankargouda P, Sachin CS, Gargi SS and Roopa SR. Clinico-pathological prognosticators in oral squamous cell carcinoma: An update Translational. Research in Oral Oncology. 2017; (2): 1-14.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Majumdar</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Shankargouda</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Sachin</surname>
							<given-names>CS</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>Gargi SS and Roopa SR</collab>
					</person-group>
					<article-title>Clinico-pathological prognosticators in oral squamous cell carcinoma An update Translational</article-title>
					<source>Research in Oral Oncology</source>
					<year>2017</year>
					<issue>2</issue>
					<fpage>1</fpage>
					<lpage>14</lpage>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg. 1994; 168 (5): 494-8.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mamelle</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Pampurik</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Luboinski</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Lancar</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Lusinchi</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Bosq</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Lymph node prognostic factors in head and neck squamous cell carcinomas</article-title>
					<source>Am J Surg</source>
					<year>1994</year>
					<volume>168</volume>
					<issue>5</issue>
					<fpage>494</fpage>
					<lpage>498</lpage>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>Oliveira MLC, Wagner VP, Sant'ana Filho M, Carrard VC, Hugo FN, Martins MD. A 10-year analysis of the oral squamous cell carcinoma profile in patients from public health centers in Uruguay. Braz Oral Res. 2015; 29 (1): 1-8.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Oliveira</surname>
							<given-names>MLC</given-names>
						</name>
						<name>
							<surname>Wagner</surname>
							<given-names>VP</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>Sant'ana Filho M.Carrard VC.Hugo FN.Martins MD</collab>
					</person-group>
					<article-title>A 10-year analysis of the oral squamous cell carcinoma profile in patients from public health centers in Uruguay</article-title>
					<source>Braz Oral Res</source>
					<year>2015</year>
					<volume>29</volume>
					<issue>1</issue>
					<fpage>1</fpage>
					<lpage>8</lpage>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>Barrios E, Garau M. Cáncer: magnitud del problema en el mundo y en Uruguay, aspectos epidemiológicos. An la Fac Med. 2017; 4 (1): 04-66.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Barrios</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Garau</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Cáncer magnitud del problema en el mundo y en Uruguay, aspectos epidemiológicos</article-title>
					<source>An la Fac Med</source>
					<year>2017</year>
					<volume>4</volume>
					<issue>1</issue>
					<fpage>04</fpage>
					<lpage>66</lpage>
				</element-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation>Barrios E, Garau M, Alonso R, Musetti C. IV atlas de incidencia del cancer en el Uruguay. Registro Nacional de Cáncer, Comisión Honoraria de lucha contra el Cáncer, 2014.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Barrios</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Garau</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Alonso</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Musetti</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<source>IV atlas de incidencia del cancer en el Uruguay</source>
					<year>2014</year>
					<publisher-loc>Registro Nacional de Cáncer</publisher-loc>
					<publisher-name>Comisión Honoraria de lucha contra el Cáncer</publisher-name>
				</element-citation>
			</ref>
			<ref id="B22">
				<label>22</label>
				<mixed-citation>Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136 (5).</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Ferlay</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Soerjomataram</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Dikshit</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Eser</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Mathers</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Rebelo</surname>
							<given-names>M</given-names>
						</name>
						<etal/>
					</person-group>
					<chapter-title>Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012</chapter-title>
					<source>Int J Cancer</source>
					<year>2015</year>
					<volume>136</volume>
					<issue>5</issue>
				</element-citation>
			</ref>
			<ref id="B23">
				<label>23</label>
				<mixed-citation>Patel RS, Clark JR, Dirven R, Wyten R, Gao K, O'Brien CJ. Prognostic factors in the surgical treatment of patients with oral carcinoma. ANZ J Surg. 2009 Jan;79(1-2):19-22.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Patel</surname>
							<given-names>RS</given-names>
						</name>
						<name>
							<surname>Clark</surname>
							<given-names>JR</given-names>
						</name>
						<name>
							<surname>Dirven</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Wyten</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Gao</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>O'Brien CJ</collab>
					</person-group>
					<article-title>Prognostic factors in the surgical treatment of patients with oral carcinoma</article-title>
					<source>ANZ J Surg</source>
					<year>2009</year>
					<month>01</month>
					<volume>79</volume>
					<issue>1-2</issue>
					<fpage>19</fpage>
					<lpage>22</lpage>
				</element-citation>
			</ref>
			<ref id="B24">
				<label>24</label>
				<mixed-citation>Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg. 1994;168(5):494-8.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mamelle</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Pampurik</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Luboinski</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Lancar</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Lusinchi</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Bosq</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Lymph node prognostic factors in head and neck squamous cell carcinomas</article-title>
					<source>Am J Surg</source>
					<year>1994</year>
					<volume>168</volume>
					<issue>5</issue>
					<fpage>494</fpage>
					<lpage>498</lpage>
				</element-citation>
			</ref>
			<ref id="B25">
				<label>25</label>
				<mixed-citation>Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67(2): 122-37.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lydiatt</surname>
							<given-names>WM</given-names>
						</name>
						<name>
							<surname>Patel</surname>
							<given-names>SG</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>O'Sullivan B.Brandwein MS.Ridge JA.Migliacci JC</collab>
					</person-group>
					<article-title>Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual</article-title>
					<source>CA Cancer J Clin</source>
					<year>2017</year>
					<volume>67</volume>
					<issue>2</issue>
					<fpage>122</fpage>
					<lpage>137</lpage>
				</element-citation>
			</ref>
			<ref id="B26">
				<label>26</label>
				<mixed-citation>Roberto De Oliveira L, Ribeiro-Silva A, Zucoloto S. Perfil da incidência e da sobrevida de pacientes com carcinoma epidermóide oral em uma população brasileira Incidence and survival profile of patients with oral squamous cell carcinoma in a Brazilian population. J Bras Patol Med Lab. 2006; 42 (5): 385-92.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<collab>Roberto De Oliveira L.Ribeiro-Silva A.Zucoloto S</collab>
					</person-group>
					<article-title>Perfil da incidência e da sobrevida de pacientes com carcinoma epidermóide oral em uma população brasileira Incidence and survival profile of patients with oral squamous cell carcinoma in a Brazilian population</article-title>
					<source>J Bras Patol Med Lab</source>
					<year>2006</year>
					<volume>42</volume>
					<issue>5</issue>
					<fpage>385</fpage>
					<lpage>392</lpage>
				</element-citation>
			</ref>
			<ref id="B27">
				<label>27</label>
				<mixed-citation>Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A ,Bray F.Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018; 144 (8): 1941-1953</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ferlay</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Colombet</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Soerjomataram</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Mathers</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Parkin</surname>
							<given-names>DM</given-names>
						</name>
						<name>
							<surname>Piñeros</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Znaor</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Bray</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods</article-title>
					<source>Int J Cancer</source>
					<year>2018</year>
					<volume>144</volume>
					<issue>8</issue>
					<fpage>1941</fpage>
					<lpage>1953</lpage>
				</element-citation>
			</ref>
			<ref id="B28">
				<label>28</label>
				<mixed-citation>Estimativa 2018: incidência de câncer no Brasil / Instituto Nacional de Câncer José Alencar Gomes da Silva. In 2017. Ministério da saúde, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA).</mixed-citation>
				<element-citation publication-type="book">
					<source>Estimativa 2018: incidência de câncer no Brasil</source>
					<person-group person-group-type="author">
						<collab>Instituto Nacional de Câncer José Alencar Gomes da Silva</collab>
					</person-group>
					<year>2017</year>
					<publisher-name>Ministério da saúde, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)</publisher-name>
				</element-citation>
			</ref>
			<ref id="B29">
				<label>29</label>
				<mixed-citation>Chan MH, Wang F, Mang W kong, Tse LA. Sex Differences in Time Trends on Incidence Rates of Oropharyngeal and Oral Cavity Cancers in Hong Kong. Ann Otol Rhinol Laryngol. 2018; 127 (12): 895-902.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Chan</surname>
							<given-names>MH</given-names>
						</name>
						<name>
							<surname>Wang</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Mang kong</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Tse</surname>
							<given-names>LA</given-names>
						</name>
					</person-group>
					<article-title>Sex Differences in Time Trends on Incidence Rates of Oropharyngeal and Oral Cavity Cancers in Hong Kong</article-title>
					<source>Ann Otol Rhinol Laryngol</source>
					<year>2018</year>
					<volume>127</volume>
					<issue>12</issue>
					<fpage>895</fpage>
					<lpage>902</lpage>
				</element-citation>
			</ref>
			<ref id="B30">
				<label>30</label>
				<mixed-citation>Momares B, Contreras G, Martínez B, Ávalos N, Carmona L. Sobrevida en Carcinoma Espinocelular de mucosa oral: análisis de 161 pacientes. Rev Chil Cir. 2014; 66 (6): 568-76.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Momares</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Contreras</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Martínez</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Ávalos</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Carmona</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>Sobrevida en Carcinoma Espinocelular de mucosa oral análisis de 161 pacientes</article-title>
					<source>Rev Chil Cir</source>
					<year>2014</year>
					<volume>66</volume>
					<issue>6</issue>
					<fpage>568</fpage>
					<lpage>576</lpage>
				</element-citation>
			</ref>
			<ref id="B31">
				<label>31</label>
				<mixed-citation>Shridhar K, Rajaraman P, Koyande S, Parikh PM, Chaturvedi P, Dhillon PK, Rajesh Dikshit P. Trends in mouth cancer incidence in Mumbai, India (1995-2009): An age-period-cohort analysis. Trends mouth cancer Incid Mumbai. 2016; 42 (2016): 66-71.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Shridhar</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Rajaraman</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Koyande</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Parikh</surname>
							<given-names>PM</given-names>
						</name>
						<name>
							<surname>Chaturvedi</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Dhillon</surname>
							<given-names>PK</given-names>
						</name>
						<name>
							<surname>Rajesh Dikshit</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Trends in mouth cancer incidence in Mumbai, India (1995-2009) An age-period-cohort analysis</article-title>
					<source>Trends mouth cancer Incid Mumbai</source>
					<year>2016</year>
					<volume>42</volume>
					<issue>2016</issue>
					<fpage>66</fpage>
					<lpage>71</lpage>
				</element-citation>
			</ref>
			<ref id="B32">
				<label>32</label>
				<mixed-citation>Salgado-Ramíre B, Rivera-Martínez CG, Altamirano-Díaz I, Salgado-Ramírez B. Frecuencia de carcinoma de cavidad oral en un Hospital de tercer nivel. Rev Sanid Milit Mex. 2014; 68 (3): 172-6.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Salgado-Ramíre</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Rivera-Martínez</surname>
							<given-names>CG</given-names>
						</name>
						<name>
							<surname>Altamirano-Díaz</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Salgado-Ramírez</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<article-title>Frecuencia de carcinoma de cavidad oral en un Hospital de tercer nivel</article-title>
					<source>Rev Sanid Milit Mex</source>
					<year>2014</year>
					<volume>68</volume>
					<issue>3</issue>
					<fpage>172</fpage>
					<lpage>176</lpage>
				</element-citation>
			</ref>
			<ref id="B33">
				<label>33</label>
				<mixed-citation>Álvarez Arias D, Munyo Estefan A, Borche G, Rodríguez Sande V, Cuello M. Cáncer de cabeza y cuello en Uruguay. Análisis de sobrevida en dos centros de referencia. Rev Méd Urug. 2018; 34 (1): 21-8.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Álvarez Arias</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Munyo Estefan</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Borche</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Rodríguez Sande</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Cuello</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Cáncer de cabeza y cuello en Uruguay Análisis de sobrevida en dos centros de referencia</article-title>
					<source>Rev Méd Urug</source>
					<year>2018</year>
					<volume>34</volume>
					<issue>1</issue>
					<fpage>21</fpage>
					<lpage>28</lpage>
				</element-citation>
			</ref>
			<ref id="B34">
				<label>34</label>
				<mixed-citation>Beovide Cortegoso AV, Koerich Laureano N, Dutra da Silva A, Krebs Danilevicz C, Sellinger Magnusson A, et al. Cell proliferation markers at the invasive tumor front of oral squamous cell carcinoma: comparative analysis in relation to clinicopathological parameters of patients. J Appl Oral Sci. 2017; 25 (3): 318-23.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Beovide Cortegoso</surname>
							<given-names>AV</given-names>
						</name>
						<name>
							<surname>Koerich Laureano</surname>
							<given-names>N</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>Dutra da Silva A.Krebs Danilevicz C.Sellinger Magnusson A</collab>
					</person-group>
					<article-title>Cell proliferation markers at the invasive tumor front of oral squamous cell carcinoma comparative analysis in relation to clinicopathological parameters of patients</article-title>
					<source>J Appl Oral Sci</source>
					<year>2017</year>
					<volume>25</volume>
					<issue>3</issue>
					<fpage>318</fpage>
					<lpage>323</lpage>
				</element-citation>
			</ref>
			<ref id="B35">
				<label>35</label>
				<mixed-citation>Brandizzi D, Gandolfo M, Velazco ML, Cabrini RL, Lanfranchi HE. Clinical features and evolution of oral cancer: A study of 274 cases in Buenos Aires, Argentina. Med Oral Patol Oral Cir Bucal. 2008; 13 (9): E544-8.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Brandizzi</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Gandolfo</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Velazco</surname>
							<given-names>ML</given-names>
						</name>
						<name>
							<surname>Cabrini</surname>
							<given-names>RL</given-names>
						</name>
						<name>
							<surname>Lanfranchi</surname>
							<given-names>HE</given-names>
						</name>
					</person-group>
					<article-title>Clinical features and evolution of oral cancer A study of 274 cases in Buenos Aires, Argentina</article-title>
					<source>Med Oral Patol Oral Cir Bucal</source>
					<year>2008</year>
					<volume>13</volume>
					<issue>9</issue>
					<fpage>E544</fpage>
					<lpage>E548</lpage>
				</element-citation>
			</ref>
			<ref id="B36">
				<label>36</label>
				<mixed-citation>Siriwardena BS, Tilakaratne A, Amaratunga EAPD, Tilakaratne WM. Demographic, aetiological and survival differences of oral squamous cell carcinoma in the young and the old in Sri Lanka. Oral Oncol. 2006; 42 (8): 831-6.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Siriwardena</surname>
							<given-names>BS</given-names>
						</name>
						<name>
							<surname>Tilakaratne</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Amaratunga</surname>
							<given-names>EAPD</given-names>
						</name>
						<name>
							<surname>Tilakaratne</surname>
							<given-names>WM</given-names>
						</name>
					</person-group>
					<article-title>Demographic, aetiological and survival differences of oral squamous cell carcinoma in the young and the old in Sri Lanka</article-title>
					<source>Oral Oncol</source>
					<year>2006</year>
					<volume>42</volume>
					<issue>8</issue>
					<fpage>831</fpage>
					<lpage>836</lpage>
				</element-citation>
			</ref>
			<ref id="B37">
				<label>37</label>
				<mixed-citation>Muradás Girardi F, Fuga GR, Callai T, Fernandes Bianchi M, Girardi FM. Histopatological differences between genders in patients witH oral squamous cell carcinoma. Clin Biomed Res. 2017;37 (3): 147-50.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Muradás Girardi</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Fuga</surname>
							<given-names>GR</given-names>
						</name>
						<name>
							<surname>Callai</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Fernandes Bianchi</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Girardi</surname>
							<given-names>FM</given-names>
						</name>
					</person-group>
					<article-title>Histopatological differences between genders in patients witH oral squamous cell carcinoma</article-title>
					<source>Clin Biomed Res</source>
					<year>2017</year>
					<volume>37</volume>
					<issue>3</issue>
					<fpage>147</fpage>
					<lpage>150</lpage>
				</element-citation>
			</ref>
			<ref id="B38">
				<label>38</label>
				<mixed-citation>Jie W, Bai J, Li B. Clinicopathologic Analysis of Oral Squamous Cell Carcinoma After 125 I Interstitial Brachytherapy. Technol Cancer Res Treatmen. 2018;17:1-5.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jie</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Bai</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<article-title>Clinicopathologic Analysis of Oral Squamous Cell Carcinoma After 125 I Interstitial Brachytherapy</article-title>
					<source>Technol Cancer Res Treatmen</source>
					<year>2018</year>
					<volume>17</volume>
					<fpage>1</fpage>
					<lpage>5</lpage>
				</element-citation>
			</ref>
			<ref id="B39">
				<label>39</label>
				<mixed-citation>Saira Fiaz Khan M, Rauf Khattak M, Rawail A, Malik S. Epidemiological and clinical correlates of oral squamous cell carcinoma in patients from north-west Pakistan. J Pak Med Assoc. 2019; 69 (8): 1074-1078</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Saira Fiaz Khan</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Rauf Khattak</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Rawail</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Malik</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Epidemiological and clinical correlates of oral squamous cell carcinoma in patients from north-west Pakistan</article-title>
					<source>J Pak Med Assoc</source>
					<year>2019</year>
					<volume>69</volume>
					<issue>8</issue>
					<fpage>1074</fpage>
					<lpage>1078</lpage>
				</element-citation>
			</ref>
			<ref id="B40">
				<label>40</label>
				<mixed-citation>Gul H, Asif F, Ghaffar I, Anwar MA, Tayyab MA, Kashif M. Epidemiology and pathological trends in oral squamous cell carcinoma in a local tertiary care hospital. Int J Community Med Public Heal. 2017; 4 (12): 4440.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gul</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Asif</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Ghaffar</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Anwar</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Tayyab</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Kashif</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Epidemiology and pathological trends in oral squamous cell carcinoma in a local tertiary care hospital</article-title>
					<source>Int J Community Med Public Heal</source>
					<year>2017</year>
					<volume>4</volume>
					<issue>12</issue>
					<fpage>4440</fpage>
					<lpage>4440</lpage>
				</element-citation>
			</ref>
			<ref id="B41">
				<label>41</label>
				<mixed-citation>Leite AA, Leonel ACL da S, de Castro JFL, Carvalho EJ de A, Vargas PA, Kowalski LP, da Cruz Perez DE. Oral squamous cell carcinoma: A clinicopathological study on 194 cases in northeastern Brazil. A cross-sectional retrospective study. Sao Paulo Med J. 2018; 136 (2):165-9.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Leite</surname>
							<given-names>AA</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>Leonel ACL da S.de Castro JFL.Carvalho EJ de A.Vargas PA.Kowalski LP.da Cruz Perez DE</collab>
					</person-group>
					<article-title>Oral squamous cell carcinoma A clinicopathological study on 194 cases in northeastern Brazil. A cross-sectional retrospective study</article-title>
					<source>Sao Paulo Med J</source>
					<year>2018</year>
					<volume>136</volume>
					<issue>2</issue>
					<fpage>165</fpage>
					<lpage>169</lpage>
				</element-citation>
			</ref>
			<ref id="B42">
				<label>42</label>
				<mixed-citation>Álvarez Martínez E, Preciado A, Montoya Fernández SA, Jiménez Gómez R, Posada A. Características clínico-histopatológicas del carcinoma escamocelular bucal, Colombia. Rev Cubana Estomatol. 2010; 47 (1): 81-95.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Álvarez Martínez</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Preciado</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Montoya Fernández</surname>
							<given-names>SA</given-names>
						</name>
						<name>
							<surname>Jiménez Gómez</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Posada</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Características clínico-histopatológicas del carcinoma escamocelular bucal, Colombia</article-title>
					<source>Rev Cubana Estomatol</source>
					<year>2010</year>
					<volume>47</volume>
					<issue>1</issue>
					<fpage>81</fpage>
					<lpage>95</lpage>
				</element-citation>
			</ref>
			<ref id="B43">
				<label>43</label>
				<mixed-citation>Bórquez PM, Capdeville FF, Madrid AM, Veloso MO, Cárcamo MP. Sobrevida global y por estadíos de 137 pacientes con cáncer intraoral. Experiencia del Instituto Nacional del Cáncer.Rev. Chilena de Cirugía.2011; 63 (4): 351-355.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bórquez</surname>
							<given-names>PM</given-names>
						</name>
						<name>
							<surname>Capdeville</surname>
							<given-names>FF</given-names>
						</name>
						<name>
							<surname>Madrid</surname>
							<given-names>AM</given-names>
						</name>
						<name>
							<surname>Veloso</surname>
							<given-names>MO</given-names>
						</name>
						<name>
							<surname>Cárcamo</surname>
							<given-names>MP</given-names>
						</name>
					</person-group>
					<article-title>Sobrevida global y por estadíos de 137 pacientes con cáncer intraoral Experiencia del Instituto Nacional del Cáncer.Rev</article-title>
					<source>Chilena de Cirugía</source>
					<year>2011</year>
					<volume>63</volume>
					<issue>4</issue>
					<fpage>351</fpage>
					<lpage>355</lpage>
				</element-citation>
			</ref>
			<ref id="B44">
				<label>44</label>
				<mixed-citation>Bonfante GM, Machado CJ, Souza PEA, Andrade EIG, Acurcio F de A, Cherchiglia ML. Sobrevida de cinco anos e fatores associados ao câncer de boca para pacientes em tratamento oncológico ambulatorial pelo Sistema Único de Saúde, Brasil. Cad Saude Publica. 2014; 30 (5): 983-97.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bonfante</surname>
							<given-names>GM</given-names>
						</name>
						<name>
							<surname>Machado</surname>
							<given-names>CJ</given-names>
						</name>
						<name>
							<surname>Souza</surname>
							<given-names>PEA</given-names>
						</name>
						<name>
							<surname>Andrade</surname>
							<given-names>EIG</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>Acurcio F de A.Cherchiglia ML</collab>
					</person-group>
					<article-title>Sobrevida de cinco anos e fatores associados ao câncer de boca para pacientes em tratamento oncológico ambulatorial pelo Sistema Único de Saúde, Brasil</article-title>
					<source>Cad Saude Publica</source>
					<year>2014</year>
					<volume>30</volume>
					<issue>5</issue>
					<fpage>983</fpage>
					<lpage>997</lpage>
				</element-citation>
			</ref>
			<ref id="B45">
				<label>45</label>
				<mixed-citation>Brandizzi D, Gandolfo M, Velazco ML CR, Lanfranchi HE. Clinical features and evolution of oral cancer: a study of 274 cases in Buenos Aires, Argentina.Med Oral Patol Oral Cir Bucal. 2008;13:E544-8.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Brandizzi</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Gandolfo</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Velazco ML</surname>
							<given-names>CR</given-names>
						</name>
						<name>
							<surname>Lanfranchi</surname>
							<given-names>HE</given-names>
						</name>
					</person-group>
					<article-title>Clinical features and evolution of oral cancer a study of 274 cases in Buenos Aires, Argentina.Med Oral Patol Oral Cir</article-title>
					<source>Bucal</source>
					<year>2008</year>
					<volume>13</volume>
					<fpage>E544</fpage>
					<lpage>E548</lpage>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
		<fn fn-type="other" id="fn1">
			<label>Nota contribución de autoría:</label>
			<p> 1)Concepción y diseño del estudio 2)Adquisición de datos 3) Análisis de datos 4) Discusión de los resultados 5)Redacción del manuscrito 6) Aprobación de la versión final del manuscrito NGU ha contribuido en 1, 2, 3, 4, 5 y 6 VBC ha contribuido en 1, 4, 5 y 6</p>
		</fn>
		<fn fn-type="other" id="fn2">
			<label>Nota de aceptación:</label>
			<p> Este artículo fue aprobado por la editora de la revista Mag. Dra. Vanessa Pereira-Prado</p>
		</fn>
	</fn-group>
	</back>
<!--	<sub-article article-type="translation" id="s1" xml:lang="en">
		<front-stub>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Research</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Profile of oral squamous cell carcinoma at the Anatomic Pathology Laboratory of the School of Dentistry of Universidad de la República, 1982-2015 period</article-title>
			</title-group>
			<abstract>
				<title>Abstract</title>
				<p>Oral squamous cell carcinoma is the most frequent malignant oral pathology, mainly associated with tobacco, alcohol, and human papillomavirus.</p>
				<p>This study aimed to determine the profile of this pathology at the Laboratory of Anatomic Pathology of the School of Dentistry of Universidad de la República between 1982 and 2015. A retrospective, cross-sectional, analytical study was conducted. Statistical analysis performed using the Cox model, Fisher’s exact test, and the Kaplan-Meier method. Of 207 cases, 59.9% were men and 98.5% older than 40. It is usually located on the tongue, with a predominance of histopathologically well and moderately differentiated carcinomas. There was an association between histopathological grade, gender, and age, with an average survival time of 2.36 years and a 43% five-year survival rate. The study allowed us to determine the situation of this pathology in a reference health service and create a database for subsequent studies. </p>
			</abstract>
			<kwd-group xml:lang="en">
				<title>Keywords:</title>
				<kwd>head and neck squamous cell carcinoma</kwd>
				<kwd>epidemiology</kwd>
				<kwd>survival</kwd>
			</kwd-group>
		</front-stub>
		<body>
			<sec sec-type="intro">
				<title>Introduction and background</title>
				<p>Oral squamous cell carcinoma (OSCC) is the most frequent oral malignancy, accounting for 2%-3% of all malignancies and up to 80%-90% of those of the oral cavity <xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref>.</p>
				<p>OSCC is a solid malignant tumor originating in the stratified squamous epithelium of the upper aerodigestive tract’s mucosa, characterized by varying degrees of histological differentiation and a high invasive and metastatic potential<xref ref-type="bibr" rid="B9"><sup>9</sup></xref>. Its etiology is mainly associated with risk factors such as tobacco, alcohol, and human papillomavirus 16 and 18 (HPV) <xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref>.</p>
				<p>In 2018, the Global Cancer Observatory (GLOBOCAN) reported the following data for Uruguay: 15,101 new cancer cases in a population of 3,469,551 people, with 8,589 deaths and a 5-year prevalence of 35,478 cases, according to sources from the National Cancer Registry (NCR) and the World Health Organization (WHO) <xref ref-type="bibr" rid="B14"><sup>14</sup></xref>.</p>
				<p>The cancer epidemiological situation of Uruguay-recently published by the NCR- reported the following data on oropharyngeal cancer for 2011-2015 (expressed in adjusted rates per 100,000 inhabitants): a total of 1,529 new cases (1,107 men and 422 women), mainly on the tongue (378 cases) regardless of lingual anatomical site, an incidence of 10.17 and 2.81 for men and women respectively, and a 6.67 mortality rate in men and of 1.21 in women<xref ref-type="bibr" rid="B15"><sup>15</sup></xref>.</p>
				<p>Morphologically, OSCC is a malignant epithelial neoplastic proliferation, consisting of nests, cords, and islets that resemble-to a greater or lesser degree-the original squamous epithelium of the lining mucosa. Currently, OSCC histological grading is based on the WHO’s histological classification and the tumor-invasive front: well differentiated, moderately differentiated, and undifferentiated OSCC <xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref>. </p>
				<p>OSCC is an aggressive neoplasm with unpredictable biological behavior and an unfavorable prognosis<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. The aggressiveness of this malignancy is evident, as despite currently available therapeutic strategies-including surgical removal either exclusively or in combination with radiation therapy and/or chemotherapy -the survival and recurrence rates after five years is poor, where only 50% of the patients diagnosed and treated survive<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref>, a situation that has remained unchanged over the last five decades <xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Its prognosis is related to factors such as tumor size, presence of metastatic lymph nodes, tumor differentiation, invasion of adjacent structures, location, and treatment <xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref>. The TNM staging system, where T stands for <italic>primary tumor</italic>, N for <italic>regional lymph nodes</italic> and M for <italic>distant metastases</italic>, is a universal method of staging the disease in cancer patients, which allows clinicians to make therapeutic decisions. It was updated in 2017 for each topography, in addition to identifying OSCC HPV+ and HPV <xref ref-type="bibr" rid="B25"><sup>25</sup></xref>. </p>
				<p>This study aimed to determine this pathology profile at the Laboratory of Anatomic Pathology of the School of Dentistry (LAPFO) of Universidad de la República between 1982 and 2015. It also aimed to describe its distribution according to clinical-morphological parameters (age, gender, location, and histopathological grade) and determine its survival rate.</p>
			</sec>
			<sec sec-type="methods">
				<title>Methodology</title>
				<sec>
					<title>1- Ethical considerations</title>
					<p>This study was conducted with the approval of the Ethics Committee of the School of Dentistry of Universidad de la República, Montevideo, Uruguay (File 163/16).</p>
				</sec>
				<sec>
					<title>2- Study design</title>
					<p>A retrospective, cross-sectional and analytical study, with convenience non-probability sampling according to the proposed inclusion and exclusion criteria. The population included all of LAPFO’s biopsy records (11,321) for 1982-2015. The sample included all the cases with histopathological diagnosis of OSCC of the oral mucosa. A sample of 207 OSCC cases (1.8%) was obtained from the total biopsy records for that period (11,321); they met the inclusion and exclusion criteria set out below.</p>
				</sec>
				<sec>
					<title>3- Inclusion and exclusion criteria</title>
					<p><italic>Inclusion criteria:</italic> OSCC with full morphological, clinical data, and recorded variables: age, gender, location, and histopathological grade of the lesion. The OSCC histopathological diagnosis accepted was that recorded in the biopsy report that met the WHO’s histological criteria of malignancy (well differentiated, moderately differentiated, and undifferentiated). Reassessing the histopathological diagnosis was considered when the grade was not detailed according to the established criteria, but it was not necessary in any case. If there were two records (incisional and excisional biopsy) for one patient, it was considered a single case-to avoid duplication-and the histological grading recorded was the one for the excisional biopsy. In contrast, for the date of onset of the disease, the one recorded in the first biopsy with an OSCC diagnosis was considered.</p>
					<p>A sample was used to determine the survival rate of OSCC patients; the inclusion criterion was that the record should include the patient’s identity card number, which was necessary to find the patient in the NCR’s database (n=99).</p>
					<p><italic>Exclusion criteria:</italic> Cases with incomplete data, missing variables (age, gender, location, and histological grading) were excluded.</p>
				</sec>
				<sec>
					<title>4- Statistical analysis</title>
					<p>Descriptive statistics were used to establish significant relationships between the different clinical-morphological parameters through Fisher’s exact test. Survival curves were created using Kaplan Meier’s methodology. Hypothesis tests were performed at a 5% level, and Survival analysis using software R. The data were analyzed using the Cox proportional-hazards model and based on the potential influence of gender, age, histopathological grade, and clustered location of tumors. The variables were selected with a backward procedure; after adjusting the models, the validity of the proportionality assumption was verified.</p>
				</sec>
			</sec>
			<sec sec-type="results">
				<title>Results</title>
				<p>The results are shown in <xref ref-type="table" rid="t5">Chart 1</xref>. An age range between 16 and 99 was recorded, with an average of 63 years ± 12.57, 41.5% (86) between 41 and 60, and 47.8% (99) between 61 and 80. In the sample, 59.9% (124) were male, with a male: female ratio of 1.5:1. Regarding histopathological grade, 44.4% (92) were well differentiated carcinomas, 44.9% (93) moderately differentiated and 10.6% (22) undifferentiated. The most frequent location was the tongue-26.6% (55)-and the alveolar ridge-23.7% (49). </p>
				<p>
					<table-wrap id="t5">
						<label>Chart 1:</label>
						<caption>
							<title>Univariate frequencies of OSCC (n=207)</title>
						</caption>
						<graphic xlink:href="1688-9339-ode-22-36-34-gt5.png"/>
					</table-wrap>
				</p>
				<p>Variable correlation showed that the histopathological grade concerning gender and age was significant, showing that men have a higher rate of moderately differentiated OSCC and women, a higher rate of well-differentiated OSCC (p-value=0.031) (<xref ref-type="table" rid="t6">Table 1</xref>); as for age, those over 81 have a higher rate of undifferentiated OSCC (p-value=0.027) (<xref ref-type="table" rid="t7">Table 2</xref>). </p>
				<p>
					<table-wrap id="t6">
						<label>Table 1:</label>
						<caption>
							<title>Correlation between histopathological grade and gender</title>
						</caption>
						<graphic xlink:href="1688-9339-ode-22-36-34-gt6.png"/>
						<table-wrap-foot>
							<fn id="TFN2">
								<p>Fisher’s exact test p-value: 0.031</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>
					<table-wrap id="t7">
						<label>Table 2:</label>
						<caption>
							<title>Correlation between histopathological grade and age</title>
						</caption>
						<graphic xlink:href="1688-9339-ode-22-36-34-gt7.png"/>
						<table-wrap-foot>
							<fn id="TFN3">
								<p>Fisher’s exact test p-value: 0.027</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>Multivariate analysis of location showed no significant association, possibly due to the multiple locations of OSCC in the oral mucosa. In this study, locations were grouped into eight categories. In women, the most frequent locations were the alveolar ridge-28.9% (24)-and the tongue-26.5% (22)-while in men, OSCC appeared in the tongue in 26.6% of cases (33), and in 20.2% of cases (25), in the alveolar ridge.</p>
				<p>Survival analysis was performed with a sample of 99 patients, among whom death occurred in 57 cases; the rest corresponded to censoring. The survival curve <xref ref-type="fig" rid="f3">(Figure 1)</xref> was created, from which it was estimated that the average survival time was 2.36 years with a confidence interval (1.60-8.24), and the five-year survival rate survival was 43%, without considering the stages of the TNM system as they were not included in the records.</p>
				<p>
					<fig id="f3">
						<label>Fig. 1:</label>
						<caption>
							<title>Survival curve, Kaplan-Meier</title>
						</caption>
						<graphic xlink:href="1688-9339-ode-22-36-34-gf3.jpg"/>
					</fig>
				</p>
				<p>According to gender, age, histopathological grade, and location, a statistically significant correlation was found with the histological grade when associating the risk of death. The final model is presented in <xref ref-type="table" rid="t8">Chart 2</xref>, which shows that patients diagnosed with moderately differentiated OSCC have almost twice the risk of death than patients with well differentiated OSCC (p-value 0.031). When analyzing undifferentiated OSCCs, death occurred in all cases, approximately seven years after follow-up, unlike well differentiated OSCCs, which at the end of the study still had patients that were alive (<xref ref-type="fig" rid="f4">Fig. 2</xref>)<bold>.</bold></p>
				<p>
					<table-wrap id="t8">
						<label>Chart 2:</label>
						<caption>
							<title>Final Cox proportional-hazards model</title>
						</caption>
						<graphic xlink:href="1688-9339-ode-22-36-34-gt8.png"/>
					</table-wrap>
				</p>
				<p>
					<fig id="f4">
						<label>Fig. 2:</label>
						<caption>
							<title>Survival curves according to histopathological grade</title>
						</caption>
						<graphic xlink:href="1688-9339-ode-22-36-34-gf4.jpg"> </graphic>
					</fig>
				</p>
			</sec>
			<sec sec-type="discussion">
				<title>Discussion</title>
				<p>It is essential to study OSCC due to its high morbidity and mortality. It is instrumental to obtain relevant information to compare results with other centers specialized in oral pathology, providing knowledge on survival and clinical-pathological characteristics.</p>
				<p>This study made it possible to obtain institutional information for the School of Dentistry of Universidad de la República, establishing the OSCC profile at LAPFO; this allowed us to create a significant database for future studies. </p>
				<p>This study had some limitations given the lack of proper anatomical-pathological recording, making TNM staging, and risk factor assessment difficult. Still, it was significant to have a cohort of 99 patients for survival analysis. </p>
				<p>In this study, 59.9% of OSCC cases affected men, a figure in line with the literature <xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref>; however, differences were found between the m:f ratio of our study (1.5:1) and that reported by the National Cancer Institute (INCA) in Brazil, which reported a rate higher than 3.7:1 <xref ref-type="bibr" rid="B28"><sup>28</sup></xref> and that recently reported by the NCR in Uruguay, which published a 3.6:1 ratio for both men and women <xref ref-type="bibr" rid="B15"><sup>15</sup></xref>. The highest frequency among men matches the data reported in GLOBOCAN 2018 <xref ref-type="bibr" rid="B14"><sup>14</sup></xref> and by other authors, where OSCC is two or three times more frequent in men in most ethnic groups. In recent years, there has been an increasing trend of OSCC among women due to increased tobacco consumption. This data could explain the 1.5:1 ratio of our study <xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref>.</p>
				<p>A retrospective study published in 2014 by Momares et al., including 217 patients diagnosed with OSCC between 1989 and 2010 and conducted at the Department of Oral Pathology of the School of Dentistry of Universidad Mayor de Chile, showed similar results to those of our study. The results were compared, and it was found that distribution by gender, ratio between genders, age range, and average age were almost identical. The tongue and alveolar ridge were the most frequent locations for both, with some differences in the remaining locations. Regarding histological differentiation, both studies found that well differentiated and moderately differentiated OSCCs were more prevalent than undifferentiated OSCCs <xref ref-type="bibr" rid="B30"><sup>30</sup></xref>. </p>
				<p>Regarding the age of appearance of OSCC in our study, the mean age was 63±12.57, with an age range of 16 to 99, an OSCC frequency of 41.5% between 41 and 60, increasing to 47.8% in the 61-80 age group. Oliveira et al. in 2015 reported an average age of 60.75±11.26 years in a public hospital in Uruguay, similar to the one observed in this study(19). The literature reports that over 90% of cases are individuals over 40, and more than 50% occur in individuals over 65. In our study, 98.5% occurred in individuals over 40, and 57% in individuals over 60 <xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B33"><sup>33</sup></xref>.</p>
				<p>Regarding the onset age of OSCC according to gender, 80% of women and 96% of men are aged between 41 and 80; of those groups, over 50% are in the highest range (61 to 80). In the age range analysis, we found no OSCC records for men in the group under 40, while in the group over 81, women recorded a figure almost three times higher than men.</p>
				<p>The most frequent location was the tongue-26.6%-in line with a study conducted at the Laboratory of Anatomic Pathology of INCA of Uruguay in 2017, as reported in the literature in most OSCC studies <xref ref-type="bibr" rid="B34"><sup>34</sup></xref>. There is a difference regarding the second most frequent location (alveolar ridge: 23.7%), which most studies report to be the floor of the mouth and/or palate. This may be linked to how OSCC locations are grouped <xref ref-type="bibr" rid="B35"><sup>35</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B37"><sup>37</sup></xref>.</p>
				<p>Our histopathological grading results are similar to those obtained by Wei-ping Jie et al.: 90.8% of the cases reported were well differentiated and moderately differentiated OSCC <xref ref-type="bibr" rid="B38"><sup>38</sup></xref>. Other studies showed similar data. Sairay et al. showed that 52% of OSCC were moderately differentiated and 42% well differentiated in Pakistan and for the 2015-2016 period <xref ref-type="bibr" rid="B39"><sup>39</sup></xref>, while Gul et al. found that 43% of patients in a tertiary hospital in southern Punjab India had well differentiated OSCC, 38%, moderately differentiated OSCC, and 20%, undifferentiated OSCC <xref ref-type="bibr" rid="B40"><sup>40</sup></xref>. In 2018, Read et al. studied OSCC in a Brazilian population with low economic development, with n=194 cases; 54.6% were well differentiated, 37.1%, moderately differentiated, and 5.2%, undifferentiated carcinomas. Therefore, this study has a similar profile to that of our study <xref ref-type="bibr" rid="B41"><sup>41</sup></xref>. </p>
				<p>When connecting variables, we found a statistical significance in OSCC histopathological grade in relation to gender and age. Men had a higher rate of moderately differentiated carcinomas, and women a higher rate of well differentiated OSCC. This indicates that the rate of undifferentiated carcinomas increases with age. This matches the results of a study published in 2010 on the clinical-histopathological characteristics of OSCC at San Vicente de Paúl University Hospital, Colombia <xref ref-type="bibr" rid="B42"><sup>42</sup></xref>.</p>
				<p>The five-year survival rate of OSCC patients was 43%, similar to that reported by Momares et al. in Chile, which was 46%, while their average survival time was 6.9 years, higher than that found in our study, which was 2.36 years <xref ref-type="bibr" rid="B30"><sup>30</sup></xref>. Other authors report a survival rate ranging from 30% to 50% for OSCC<xref ref-type="bibr" rid="B33"><sup>33</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref>. </p>
				<p>Oliveira et al. show an even lower overall survival rate, with a 24% five-year survival <xref ref-type="bibr" rid="B19"><sup>19</sup></xref>. In 2014, Bonfante et al. conducted a national study of Brazil’s Unified Health System for 2000-2006. They reported a five-year survival rate of 4.6-years for mouth cancer, and a five-year overall survival rate of 2.6-years, similar to our findings (2.36 years) <xref ref-type="bibr" rid="B44"><sup>44</sup></xref>. Another study with 274 cases from the University of Buenos Aires (Argentina) evaluated overall survival for oral cancer and reported a five-year survival rate of 39% <xref ref-type="bibr" rid="B45"><sup>45</sup></xref>. </p>
			</sec>
			<sec sec-type="conclusions">
				<title>Conclusions</title>
				<p>In general, OSCC studies in Uruguay are scarce, mainly regarding patient prognosis and survival. Retrospective studies such as this one have significant limitations given the lack of complete records, missing-in most cases-relevant clinical data to establish a TNM staging system, and mainly due to the lack of patient follow-up. However, these descriptive studies are a source of hypotheses for further analytical studies.</p>
				<p>Considering the high mortality and morbidity of OSCC, health professionals should consider the importance of early detection of these injuries and education on known risk factors, such as tobacco, alcohol, and HPV infection, bearing in mind that late diagnosis is one of the main factors concerning poor prognosis.</p>
			</sec>
		</body>
		<back>
			<fn fn-type="other" id="fn3">
				<label>Authorship contribution</label>
				<p> 1) Conception and design of study 2) Acquisition of data 3) Data analysis 4) Discussion of results 5) Drafting of the manuscript 6) Approval of the final version of the manuscript NGU has contributed in 1, 2, 3, 4, 5, and 6. VBC has contributed in 1, 4, 5, and 6.</p>
			</fn>
			<fn fn-type="other" id="fn4">
				<label>Editor’s opinion:</label>
				<p> This article has been accepted by the Odontoestomatología’s editor Dra. Vanessa Pereira-Prado</p>
			</fn>
		</back>
	</sub-article>-->
</article>